Combined plasma and tissue genotyping of EGFR T790M benefits NSCLC patients: a real‐world clinical example

Acquired resistance to epidermal growth factor receptor (EGFR)‐tyrosine kinase inhibitors (TKIs) is a prevalent clinical problem in the management of advanced non‐small‐cell lung cancer (NSCLC) with TKI‐sensitizing mutations in the EGFR gene. Third‐generation EGFR‐TKIs have demonstrated potent activ...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Bing, Zhao, Chengzhi, Li, Jun, Zhao, Jiuzhou, Ren, Pengfei, Yang, Ke, Yan, Chi, Sun, Rui, Ma, Jie, Guo, Yongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487696/
https://www.ncbi.nlm.nih.gov/pubmed/30927306
http://dx.doi.org/10.1002/1878-0261.12481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487696/
https://www.ncbi.nlm.nih.gov/pubmed/30927306
http://dx.doi.org/10.1002/1878-0261.12481

Ejemplares similares